Navigation Links
Genesis Biopharma's Scientific and Medical Advisory Board Welcomes Dr. Steven A. Rosenberg, Chief of the Surgery Branch at the NCI
Date:11/17/2011

pharma.com/">www.genesis-biopharma.com.

Forward-Looking Statements

The foregoing announcement contains forward-looking statements that can be identified by such terminology as "expects", "hopes", "potential", "suggests", "bodes", "may", "should", "could", or similar expressions.  Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements.  In particular, management's expectations regarding future research, development and/or commercial results could be affected by, among other things, uncertainties relating to clinical trials and product development; availability of future financing; unexpected regulatory delays or government regulation generally; the company's ability to obtain or maintain patent and other proprietary intellectual property protection; and competition in general.  Forward-looking statements speak only as of the date they are made.  The company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.


'/>"/>
SOURCE Genesis Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Triple Analysis: Prostate Cancer, Angiogenesis and Peptides
2. ThermoGenesis Corp. to Announce First Quarter Fiscal 2012 Results on November 10, 2011
3. Genesis Biopharma Signs Worldwide License Agreement with the NIH for Adoptive Cell Therapy to Treat a Variety of Cancers
4. Efficacy Data from Phase III VELOUR Trial in Colorectal Cancer to be Presented at Angiogenesis Foundations 2011 M. Judah Folkman International Conference in Cambridge, Mass.
5. Genesis Biopharma Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise
6. ThermoGenesis Reports Fourth Quarter and Year End 2011 Results; Annual Net Loss Reduced by More Than 50 Percent
7. ThermoGenesis Presentation at Rodman & Renshaw Conference
8. Genesis Biopharma Announces Letter to Shareholders Posted to Website
9. ThermoGenesis Names Former Applied Imaging CEO Robin Stracey to Board of Directors, Replacing Dr. Mahendra Rao
10. Mummy News: Genesis Medical Imaging Mobile CT Scan Unit Helps Chicagos Field Museum Discover Ancient Secrets
11. Genesis Biopharma to Hold Business Update Conference Call on June 29
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... JERUSALEM , May 5, 2015 ... ) ( http://www.oramed.com ), a clinical-stage pharmaceutical company ... systems, announced today that the company will present ... Oppenheimer 16th Annual Israeli Conference , ,Date: ... ,Presenter:       Nadav Kidron , Chief Executive Officer ...
(Date:5/5/2015)... China , May 5, 2015 Faced with ... rising public health awareness, China,s medical ... the markets with the largest demands have been ... Guangzhou and other first-tier cities. However, the entry ... short time makes these "high-end" markets in first-tier cities increasingly ...
(Date:5/5/2015)... , May 5, 2015  The Association of ... of Recognition™ to The Preoperative Stop and Go ... Ph.D. and Mauricio Gonzalez , M.D., anesthesia providers ... Preoperative Stop and Go Sign product is distributed by ... anesthesia management company, and is in compliance with the ...
Breaking Medicine Technology:Oramed to Present at Upcoming Conferences 2Oramed to Present at Upcoming Conferences 3MEDITEXPO JIANGSU 2015 is to Help Medical Device Companies Explore Business Opportunities in Wider Markets 2MEDITEXPO JIANGSU 2015 is to Help Medical Device Companies Explore Business Opportunities in Wider Markets 3MEDITEXPO JIANGSU 2015 is to Help Medical Device Companies Explore Business Opportunities in Wider Markets 4The Preoperative Stop and Go Sign Interactive Checklist Awarded AORN Seal of Recognition 2The Preoperative Stop and Go Sign Interactive Checklist Awarded AORN Seal of Recognition 3
... of the future is on display – and in use ... benefit hospitals and patients nationwide. Princeton HealthCare System ... to replace its downtown Princeton facility, has taken the extraordinary ... hospital,s proposed patient room in its existing hospital. ...
... Based on its recent analysis of the ... QRxPharma Limited with the 2010 North American Frost ... the Year for MoxDuo® immediate-release (IR) (Q8003IR) – ... of pain that also addresses some major challenges ...
Cached Medicine Technology:Hospital Room of the Future Debuts in New Jersey 2Hospital Room of the Future Debuts in New Jersey 3Hospital Room of the Future Debuts in New Jersey 4Frost & Sullivan Recognizes QRxPharma for Innovative Pain Relief Product MoxDuo 2Frost & Sullivan Recognizes QRxPharma for Innovative Pain Relief Product MoxDuo 3Frost & Sullivan Recognizes QRxPharma for Innovative Pain Relief Product MoxDuo 4
(Date:5/5/2015)... Hiliary Critchley, Senior Manager for ... the 24th Annual WEDI National Conference ... Scottsdale, AZ. WEDI, the Workgroup for Electronic Data ... the use of health IT to create efficiencies ... of Telemedicine for UnitedHealthcare will co-present with Critchley ...
(Date:5/5/2015)... New York, New York (PRWEB) May 05, ... treatment lawsuits ( http://www.testosteronelawsuithub.com/ ) filed on ... cardiovascular complications due to their use of ... forward in the federal multidistrict litigation underway ... Illinois. According to court documents dated May ...
(Date:5/5/2015)... May 05, 2015 The newly minted Regan Arts ... of Dr. Brad Reedy from his 20 years working ... asked why she chose to publish a parenting book and why ... (and publisher) is the idea that it is a journey, not ... children are on the trek sometimes together and sometimes not...that each ...
(Date:5/5/2015)... May 05, 2015 Dr. Patricia George ... hypertension (PH). A pulmonologist and pulmonary hypertension specialist at ... attending a work event when an initial idea entered ... was sitting in the audience at the 2010 PHA ... of healthcare providers – were recalling their climb up ...
(Date:5/5/2015)... " QuickPick Travel ” was featured on ... a look small, medium, and large businesses making an impact ... a business expert, conducted the business review and shared with ... to three weeks of vacation for free. , Vacations are ... explore the world. And when people are preparing for vacations, ...
Breaking Medicine News(10 mins):Health News:Optimity Advisors’ Hiliary Critchley, Telemedicine Expert, to Speak at WEDI Conference May 20th in Scottsdale, AZ 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 2Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 3Health News:World PH Day: Team PHenomenal Hope Races to Spread the Word about Pulmonary Hypertension 2Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2
... completing its review of safety,and efficacy data currently ... recommended that the pivotal Phase 3 clinical,trial FAME(TM) ... the current protocol, without change. The trial is ... of diabetic macular edema (DME). FAME is ...
... 17 "As a physician,you hear all sorts of ... Terry,D. Hashey, Medical Director of First Coast Family Medicine ... Campaign.,The most common that Dr. Hashey reports is the ... shot. "That couldn,t be farther from the truth.,The flu ...
... ImClone Systems,Incorporated (Nasdaq: IMCL ) and ... that they have established an agreement with Merck ... in,Japan. Under the terms of the agreement, ImClone ... a joint effort to develop and,following regulatory approval, ...
... - The numbers are staggering --,over 20% of people ... "It,s not the impairment or disability which creates dependency ... mainstream,social, economic and political opportunities," says Ron Nabors, Chief,Executive ... together to stand up and speak out on the,International ...
... Children in the South Bay,suffering from asthma, ... receive specialty care from Lucile Packard Children,s Hospital,physicians ... South Bay,Specialty Center in Los Gatos houses 13 ... hallmarks of its parent institution. "We,re very ...
... 16 AtriCure, Inc.,(Nasdaq: ATRC ), a ... products, today announced that results reporting on the ... to,treat atrial fibrillation (AF), were published in the ... an,electrophysiologist, and colleagues from the Oregon Heart and ...
Cached Medicine News:Health News:DSMB Supports Continuation of the Phase 3 Clinical Trial of Medidur(TM) FA for the Treatment of DME 2Health News:DSMB Supports Continuation of the Phase 3 Clinical Trial of Medidur(TM) FA for the Treatment of DME 3Health News:DSMB Supports Continuation of the Phase 3 Clinical Trial of Medidur(TM) FA for the Treatment of DME 4Health News:Flu Myths Abound in Flu Season 2Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 2Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 3Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 4Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 5Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 6Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 7Health News:CBM USA stands up and speaks out to world leaders on the International Day for the Eradication of Poverty 2Health News:Packard Children's Hospital Opens New South Bay Specialty Clinic Bringing Specialty Care Close to Home 2Health News:Published Results Using AtriCure Minimally Invasive Products 2Health News:Published Results Using AtriCure Minimally Invasive Products 3
... Analyzer (PCA) is used in conjunction ... a variety of parameters in whole ... 50 patient records and permits on-screen ... as transmission of records to a ...
... images and patient information from all ... in one central system. It simplifies ... cost-effectiveness so that healthcare professionals can ... helping people., ,Many Sources, One Solution ...
... The Attain 4194 Bipolar over-the-wire left-heart lead ... This new steroid-eluting lead has an angled ... a guidewire or a stylet delivery method, ... maneuver and position the lead in a ...
... Our Maxenon Xi300 is so bright many ... have higher gears to shift into when the ... features such as a true Hot Start and ... 300-watt xenon system that prevent failed start ups ...
Medicine Products: